Participating in OHVD

Participants will complete a range of assessments, including:

1. Vestibular Testing:
   • Dix-Hallpike Maneuver: To detect posterior or anterior Benign Paroxysmal Positional Vertigo (BPPV).
   • Supine Head Roll Test: To identify lateral BPPV.
2. Cardiovascular Monitoring:
   • Continuous monitoring of blood pressure, heart rate, and body position using the SOMNOtouch device during vestibular maneuvers and positional changes.
3. Schellong Test:
   • Manual blood pressure and heart rate measurements during a supine-to-standing test to clinically assess orthostatic hypotension.
4. Post-Treatment Testing (for BPPV participants):
   • Repeat vestibular testing after treatment to evaluate changes and compare pre- and post-treatment outcomes.

Study phases

Participation involves two phases:

Phase 1: Baseline Assessment

• Conducted during the initial visit at the Vertigo Clinic at the Centre Hospitalier Emile Mayrisch (CHEM), this phase includes:
  • Signing the informed consent form.
  • Completing vestibular testing
  • Using the SOMNOtouch device for continuous monitoring of blood pressure, heart rate, and body position.
  • Undergoing the Schellong test with manual measurements for clinical assessment of orthostatic hypotension.

Phase 2: Post-Treatment Assessment (for BPPV Participants)

• This phase involves a follow-up visit after vestibular treatment. It includes:
  • Repeat vestibular testing to evaluate changes in symptoms and cardiovascular parameters.
  • Comparing pre- and post-treatment outcomes to determine the effectiveness of the intervention.